Thousands of children could die after court backs campaign group over GM crop in Philippines, scientists warn

Scientists have warned that a court decision to block the growing of the genetically modified (GM) crop Golden Rice in the Philippines could have catastrophic consequences. Tens of thousands of children could die in the wake of the ruling, they argue.

The Philippines had become the first country – in 2021 – to approve the commercial cultivation of Golden Rice, which was developed to combat vitamin A deficiency, a major cause of disability and death among children in many parts of the world.

But campaigns by Greenpeace and local farmers last month persuaded the country’s court of appeal to overturn that approval and to revoke this. The groups had argued that Golden Rice had not been shown to be safe and the claim was backed by the court, a decision that was hailed as “a monumental win” by Greenpeace.

Many scientists, however, say there is no evidence that Golden Rice is in any way dangerous. More to the point, they argue that it is a lifesaver.

  • @nogooduser
    link
    English
    57 months ago

    The huge difference is who holds the patent.

    I don’t think that is important really. The big problem is that patents can be sold so the good guy(s) with the patent could turn out to be not as good as we hoped when someone offers them a bucket load of money.

    • @Signtist@lemm.ee
      link
      fedilink
      English
      77 months ago

      Well, yes, but that’s kinda my point. If you don’t patent, you get exploited, like how the discoverers of insulin synthesis decided not to patent, so companies patented similar, but not exact methods, and now it’s incredibly expensive. But, as you said, if you do patent, there is still a risk of exploitation if the patent holder sells to an exploitative company. However, that exploitation is still less likely than when not patenting, so I support the practice so long as patenting is still possible.

      I worked at a small nonprofit back when genes were still able to be patented; we mostly studied the condition Pseudoxanthoma Elasticum, and held the patents to a few of the genes associated with it. However, we still allowed people to research them freely - we only patented them to prevent a company like Myriad Genetics, who had been patenting genes so that they could sell expensive genetic tests, from patenting it instead. We celebrated when genes were no longer able to be patented; I imagine that the researchers working with golden rice will do the same if we’re ever lucky enough for GMO’s to no longer be able to be patented.